The Ames MPF™ test protocol was performed, according to the method’s supplier protocol (Xenometrix), with minor adaptations. As solvent control, DMSO was applied. As a positive control, for TA98 without S9 50 µg/mL 2-nitrofluorene (2NF), for TA100 without S9 2.5 µg/mL 4-nitroquinoline-1-oxide (4NQO) and for TA98 and TA100 with S9 50 µg/mL 2-aminoanthracene (2AA) was applied. Exposures were performed in triplicates in 24-well plates and 10 µL of the test substance or the controls were used per well. The pre-culture was mixed with exposure medium (10% bacteria v/v for TA98 and 5% v/v for TA100) and then 240 µL of this mix was added to each well. After 90 min of incubation at 37 °C at 250 rpm in an orbital shaker, 2.6 mL of indicator medium (Xenometrix) were added. The content of the 24-well plates was distributed into three 384-well plates. For the metabolic activation, a 15% S9 mix was prepared and kept on ice, until use and consisted of either PB/β-NF, or Aroclor 1254-induced rat liver S9 and the co-factor mix (see metabolic activation section). The 15% S9 and the co-factor mix were added as required, resulting in a final concentration of 2.25% S9 during the exposure.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.